Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Experience with the treatment of metastatic ovarian carcinoma

Summary

Metastases from non-genital sites comprise about one in six of our malignant ovarian tumors. The mean age of our 24 patients with such metastases was 43.1 years and 81% had bilateral ovarian metastases. Out of the 24 patients we studied, 21 had a gastric primary. The overall survival rate was 41.7% in 6 months, 25.0% in 1 year and 12.5% in 2 years. Patients with no extraovarian metastases had a survival rate of 75.0% at 6 moths, 62.5% at 1 year and 25.0% at 2 years after operation.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Hale RW (1968) Krukenberg tumor of the ovaries: a review of 81 records. Obstet Gynecol 32: 221–225

  2. 2.

    Israel SL, Helsel EW jr, Hausman DH (1965) The challenge of metastatic ovarian carciroma. Am J Obstet Gynecol 93: 1094–1101

  3. 3.

    Johansson H (1960) Clinical aspects of metastatic ovarian cancer of extragenital origin. Acta Obst Gynecol Scand 39: 681–697

Download references

Author information

Correspondence to K. Shiromizu.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Shiromizu, K., Kawana, T., Sugase, M. et al. Experience with the treatment of metastatic ovarian carcinoma. Arch Gynecol Obstet 243, 111–114 (1988). https://doi.org/10.1007/BF00932977

Download citation

Key words

  • Metastatic ovarian carcinoma
  • Extraovarian spread
  • Prognosis